Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Future Oncology (London, England)|November 12, 2021
Patterns of colorectal cancer diagnosis among younger adults in a real-world, population-based cohortOmar Abdel-Rahman, Hatim Karachiwala, Sheryl Koski
Medical Oncology (Northwood, London, England)|February 3, 2021
Real-world patterns of adjuvant chemotherapy treatment for patients with resected pancreatic adenocarcinomaOmar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski
International Journal of Colorectal Disease|October 17, 2020
Real-world patterns of chemotherapy administration and attrition among patients with metastatic colorectal cancerOmar Abdel-Rahman, Sheryl Koski, Karen Mulder
Journal of Cancer Research and Clinical Oncology|April 1, 2020
Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trialsOmar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski
International Journal of Colorectal Disease|May 21, 2021
Hospitalizations among early-stage colon cancer patients receiving adjuvant chemotherapy: a real-world studyOmar Abdel-Rahman, Patricia A Tang, Sheryl Koski
World Journal of Clinical Oncology|May 26, 2011
Targeting metastatic upper gastrointestinal adenocarcinomasJennifer L Spratlin, Quincy Chu, Sheryl Koski, et al.
Oncotarget|February 15, 2011
Antiangiogenic agents in advanced gastrointestinal malignancies: past, present and a novel futureKaren Mulder, Sheryl Koski, Andrew Scarfe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatmentCarla M M Prado, Vickie E Baracos, Linda J McCargar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2008
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancerJim Cassidy, Stephen Clarke, Eduardo Díaz-Rubio, et al.
Pageof 2